Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Lasa Supergenerics Ltd - 540702 - Unaudited Financial Results Along With Limited Review Report For The Quarter And Half Year Ended September 30,2019

 Pursuant to Regulation 29 and Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the meeting of Board of Directors of the company held today at the Corporate Office of the Company which was commenced at 11.00 a.m. and concluded at 4.30 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter and half year ended September 30, 2019.
13-11-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Outcome of Board Meeting

 Pursuant to Regulation 29 and Regulation 30 of SEBI (Listing obligation and disclosure requirements) Regulations, 2015, we would like to inform you that the meeting of Board of Directors of the company held today at the Corporate Office of the Company which was commenced at 11.00 a.m. and concluded at 4.30 p.m. have considered, approved and took on record the Unaudited Financial Results for the quarter and half year ended September 30, 2019. A copy of the statement of Unaudited Financial Results along with Limited Review Report submitted by the Statutory Auditors of the Company is attached herewith.
12-11-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Board Meeting Intimation for Intimation Of The Board Meeting And Closure Of Trading Window

 Lasa Supergenerics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2019 ,inter alia, to consider and approve Pursuant to Regulation 29 of the Securities and Exchange Board of the India (Listing Obligation and Disclosure Requirement) Regulation, 2015 notice is hereby given that a Meeting of the Board of Director of the Company is scheduled to be held on Tuesday, November 12, 2019 at 11.00 a.m. (IST) at the Corporate Office of the Company Inter-alia, to consider, approve and take on record Unaudited Financial Results of the Company along with Limited Review Report for the quarter / half year ended September 30, 2019, and/or to discuss any other business/matter with the permission of the Chairman. In accordance with the provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's Code of Conduct, the Trading Window shall continue to remain closed till November 15, 2019.
04-11-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Half Yearly Certificate From Practicing Company Secretary Uder Regulation 40(9) Of SEBI (LODR) Regulations 2015.

 Pursuant to Regulation 40(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 we are enclosing herewith the certificate from Amit R. Dadheech & Associates, Company Secretaries for the half year ended September 30, 2019.
25-10-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Shareholding for the Period Ended September 30, 2019

 Lasa Supergenerics Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2019. For more details, kindly Click here
22-10-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2019 received from Bigshare Services Private Limited, Registrar and Share Transfer Agent of the Company
22-10-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Statement Of Investor Complaints For The Quarter Ended September 2019

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Nidhi kulshresthaDesignation :- Company Secretary and Compliance Officer
22-10-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Compliance Certificate Under Regulation 7(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations,2015

 This is to certify that in compliance with regulation 7(2) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, all activities in relation to share transfer facility are maintained by our Share Transfer Agent i.e. Bigshare Services Private Limited having permanent SEBI Registration No INR0000001385. This certificate for the half year ended 30 September 2019 is issued in compliance with Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
19-10-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

 Lasa Supergenerics Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here
04-10-2019
Bigul

Lasa Supergenerics Ltd - 540702 - Closure of Trading Window

 This is to inform you that as per the Company's Code of Conduct for Regulating, Monitoring and Reporting of Trading by Insiders in terms of (Prohibition of Insider Trading) Regulations, 2015, as amended, the trading window for dealing in the equity shares of the Company has been closed for designated employees and their immediate relatives w.e.f. October 01, 2019 till 72 hours after the declaration of financial results (both days inclusive) for the six months ended September 30, 2019.
28-09-2019
Next Page
Close

Let's Open Free Demat Account